BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20403008)

  • 1. Understanding prevention research as a form of pseudoscience.
    Gorman DM
    Addiction; 2010 Apr; 105(4):582-3. PubMed ID: 20403008
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention programs in the 21st century: what we do not discuss in public.
    Holder H
    Addiction; 2010 Apr; 105(4):578-81. PubMed ID: 19922518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adapting evidence-based programs to new contexts: what needs to be changed?
    Smith E; Caldwell L
    J Rural Health; 2007; 23 Suppl():37-41. PubMed ID: 18237323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating qualitative and quantitative components in evaluation of case management.
    Willenbring ML
    NIDA Res Monogr; 1992; 127():223-50. PubMed ID: 1435997
    [No Abstract]   [Full Text] [Related]  

  • 5. Discussion: statistical analysis in treatment and prevention program evaluation.
    Ager JW
    NIDA Res Monogr; 1992; 117():31-40. PubMed ID: 1620204
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypothesis formulation and testing in substance use prevention research.
    Hansen WB
    NIDA Res Monogr; 1994; 139():59-74. PubMed ID: 8742551
    [No Abstract]   [Full Text] [Related]  

  • 7. Correction for the design effect in school-based substance use and abuse prevention research: sample size requirements and analysis considerations.
    Dielman TE
    NIDA Res Monogr; 1994; 139():115-25. PubMed ID: 8742554
    [No Abstract]   [Full Text] [Related]  

  • 8. New statistical methods for substance use prevention research.
    Collins LM; Seitz LA
    NIDA Res Monogr; 1994; 142():1-12. PubMed ID: 9243531
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental and quasi-experimental designs in prevention research.
    Snow DL; Tebes JK
    NIDA Res Monogr; 1991; 107():140-58. PubMed ID: 1922303
    [No Abstract]   [Full Text] [Related]  

  • 10. Research to practice: efforts to bring effective prevention to every community.
    Brounstein PJ; Gardner SE; Backer T
    J Prim Prev; 2006 Jan; 27(1):91-109. PubMed ID: 16421654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pattern-centered approach to evaluating substance use prevention programs.
    Steinman KJ; Schulenberg J
    New Dir Child Adolesc Dev; 2003; (101):87-98. PubMed ID: 15460979
    [No Abstract]   [Full Text] [Related]  

  • 12. A framework for drug abuse prevention research.
    Bukoski WJ
    NIDA Res Monogr; 1991; 107():7-28. PubMed ID: 1922313
    [No Abstract]   [Full Text] [Related]  

  • 13. Some design, measurement, and analysis pitfalls in drug abuse prevention research and how to avoid them: let your model be your guide.
    Collins LM
    NIDA Res Monogr; 1994; 139():95-114. PubMed ID: 8742553
    [No Abstract]   [Full Text] [Related]  

  • 14. Target populations and interventions in prevention research: what is high risk?
    Pentz MA
    NIDA Res Monogr; 1994; 139():75-93. PubMed ID: 8742552
    [No Abstract]   [Full Text] [Related]  

  • 15. How cultural factors influence school-based substance use prevention programs.
    Lilja J; Giota J; Hamilton D
    Subst Use Misuse; 2007; 42(2-3):485-94. PubMed ID: 17558946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug prevention research with Native-American populations: some considerations.
    Powless Sage G
    NIDA Res Monogr; 1994; 139():235-48. PubMed ID: 8742559
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention intervention research: focus and perspective.
    Cázares A
    NIDA Res Monogr; 1994; 139():5-35. PubMed ID: 8742549
    [No Abstract]   [Full Text] [Related]  

  • 18. Substance abuse prevention infrastructure: a survey-based study of the organizational structure and function of the D.A.R.E. program.
    Merrill JC; Pinsky I; Killeya-Jones LA; Sloboda Z; Dilascio T
    Subst Abuse Treat Prev Policy; 2006 Sep; 1():25. PubMed ID: 16956400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and research protocols for substance use.
    Giesbrecht N; McGowan V
    Dimens Health Serv; 1990 May; 67(4):12. PubMed ID: 2373275
    [No Abstract]   [Full Text] [Related]  

  • 20. Serendipity and pseudoscience. A look at health-related program evaluation.
    Holmes D; Teresi J; Ory M
    Eval Health Prof; 1993 Dec; 16(4):363-78. PubMed ID: 10130550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.